WallStreetZenWallStreetZen

NASDAQ: ALDX
Aldeyra Therapeutics Inc Stock Ownership - Who owns Aldeyra Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aldeyra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen MacHathaChief Development Officer2024-08-1216,041$4.74
$75.97kSell
Bruce GreenbergInterim Chief Financial Officer2024-08-1210,834$4.74
$51.31kSell
Perceptive Advisors LLC10% Owner2024-04-0537,712$4.74
$178.75kBuy
Perceptive Advisors LLC10% Owner2024-04-04140,281$4.67
$655.11kBuy
Perceptive Advisors LLC10% Owner2024-04-03309,847$4.09
$1.27MBuy
Perceptive Advisors LLC10% Owner2024-04-02186,051$3.44
$640.02kBuy
Perceptive Advisors LLC10% Owner2024-04-018,374$3.25
$27.22kBuy

1 of 1

ALDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALDX insiders and whales buy or sell their stock.

ALDX Shareholders

What type of owners hold Aldeyra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC19.87%11,865,302$78.43MInsider
Perceptive Advisors LLC15.54%9,275,851$61.31MInstitution
Knoll Capital Management LLC9.17%5,475,516$36.19MInstitution
Blackrock Inc6.35%3,790,190$25.05MInstitution
Vanguard Group Inc6.29%3,756,788$24.83MInstitution
Domain Partners VI LP3.31%1,973,389$13.04MInsider
Jesse I. Treu3.16%1,885,854$12.47MInsider
Johnson Johnson2.93%1,750,292$11.57MInsider
Todd C. Brady2.46%1,471,298$9.73MInsider
Kennedy Capital Management LLC2.46%1,468,519$9.71MInstitution

1 of 3

ALDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALDX62.12%33.70%Net Buying
TECX16.85%83.15%Net BuyingNet Buying
ABSI58.01%38.90%Net SellingNet Selling
CELC81.83%12.58%Net Buying
UPB68.96%31.04%Net Buying
View Top Biotech Stocks

Aldeyra Therapeutics Stock Ownership FAQ

Who owns Aldeyra Therapeutics?

Aldeyra Therapeutics (NASDAQ: ALDX) is owned by 62.12% institutional shareholders, 33.70% Aldeyra Therapeutics insiders, and 4.18% retail investors. Perceptive Advisors LLC is the largest individual Aldeyra Therapeutics shareholder, owning 11.87M shares representing 19.87% of the company. Perceptive Advisors LLC's Aldeyra Therapeutics shares are currently valued at $79.26M.

If you're new to stock investing, here's how to buy Aldeyra Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.